Effect of Early and Delayed Commencement of Paricalcitol in Combination with Enalapril on the Progression of Experimental Polycystic Kidney Disease
Vitamin D secosteroids are intranuclear regulators of cellular growth and suppress the renin-angiotensin system. The aim of this study was to test the hypothesis that the vitamin D receptor agonist, paricalcitol (PC), either alone or with enalapril (E) (an angiotensin-converting enzyme inhibitor), r...
Saved in:
Main Authors: | Priyanka S. Sagar, Sayanthooran Saravanabavan, Alexandra Munt, Annette T. Y. Wong, Gopala K. Rangan |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/90f1a31418fb4508a9399ef95e7e89f3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection
by: Duplancic D, et al.
Published: (2013) -
Secondary hyperparathyroidism in patient with type 2 diabetes and stages 3–4 chronic kidney disease
by: Lilit V. Egshatyan, et al.
Published: (2018) -
Feline Polycystic Kidney Disease: An Update
by: Lorie Schirrer, et al.
Published: (2021) -
Comparison between paricalcitol versus cinacalcet therapy in the management of secondary hyperparathyroidism among prevalent hemodialysis patients
by: Maha A. Behairy, et al.
Published: (2022) -
Celiac artery dissection in polycystic kidney disease
by: Koichiro Yamamoto, et al.
Published: (2021)